B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention
Role of B7-H3 on the plasticity of immune cells in shaping TME. B7-H3 are abnormally high in cancer cells and are inducible in some immune cells like antigen-presenting cells (APCs) and macrophages. TAM (tumor-associated macrophage) is the predominantly occurring immune cell in TME, and B7-H3 receptors are highly expressed on TAM. B7-H3 in the cancer cells drives the phenotypic transformation of M1 to M2 macrophage in the TME, favoring altered immune function and suppression. The autocrine action of TGF-β1 increased the expression of miR155 while downregulating the expression of miR143 in CRC and T-lymphocytes exposed to TGF-β loses their capability to kill neoplastic cells []. Also, TGF-β1 increased the proliferation of immunosuppressive Treg cells. The immunomodulatory action of B7-H3 limits the proliferation and function of CD4+ and CD8+ T-lymphocytes through the inhibition of nuclear factor kappa B (NF-κB). Furthermore, B7-H3 inhibits NK cell antitumor activity. Vδ2T, a subset of T-lymphocytes with increased cancer cell killing capacity [], is attenuated by enhanced expression of B7-H3 molecule expressed on cancer cells via a molecular pathway involving Signal transducer and activator of transcription 3/UL16 binding protein 2 (STAT3/ULBP2) signaling []. B7-H3-induced cytokine (IL-2, IL-6, IL-17) secretion by T-lymphocytes generates a conducive niche for immune suppression /immune evasion favoring CRC progression. Created with BioRender.com
Publication
B7-H3 at the crossroads between tumor plasticity and colorectal cancer progression: a potential target for therapeutic intervention. (2024) Elizabeth Varghese, et al. Cancer Metastasis Rev. 2024;43(1):115-133. Figure: F4.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Danio rerio | Vertebrates | CD4+ | CD4 | ncbigene_synonym | ighv1-1 | 378753 |
| Danio rerio | Vertebrates | CD4+ | CD4 | ncbigene_synonym | cd4-1 | 799982 |
| Danio rerio | Vertebrates | Axis | AXIS | ncbigene_synonym | acvr1ba | 30183 |
| Danio rerio | Vertebrates | miR-155 | MIR155 | ncbigene_symbol | mir155 | 100033679 |
| Danio rerio | Vertebrates | cross | CROS | ncbigene_synonym | ros1 | 245951 |
| Danio rerio | Vertebrates | IL-10 | IL10 | ncbigene_symbol | il10 | 553957 |
| Danio rerio | Vertebrates | TNF-a | TNF-A | ncbigene_synonym | tnfb | 554167 |
| Danio rerio | Vertebrates | ↑IL-6 | IL6 | ncbigene_symbol | il6 | 100885851 |
| Danio rerio | Vertebrates | B7-H3/STAT3/ | STAT3 | ncbigene_symbol | stat3 | 30767 |
| Homo sapiens | Primates | M1/M2 | MM2 | ncbigene_synonym | PNMA2 | 10687 |
| Homo sapiens | Primates | B7-H3 | B7-H3 | ncbigene_synonym | CD276 | 80381 |
| Homo sapiens | Primates | B7-H4 | B7-H4 | ncbigene_synonym | VTCN1 | 79679 |
| Homo sapiens | Primates | CD8+ | CD8 | ncbigene_synonym | CD8A | 925 |
| Homo sapiens | Primates | CD8+ | CD8 | famplex_relations | CD8B | 926 |
| Homo sapiens | Primates | CD4+ | CD4 | ncbigene_symbol | CD4 | 920 |
| Homo sapiens | Primates | miR-155 | MIR-155 | ncbigene_synonym | MIR155 | 406947 |
| Homo sapiens | Primates | killer | KILLER | ncbigene_synonym | TNFRSF10B | 8795 |
| Homo sapiens | Primates | miR-143 | MIR-143 | ncbigene_synonym | MIR143 | 406935 |
| Homo sapiens | Primates | talk | TALK | ncbigene_synonym | BMPR2 | 659 |
| Homo sapiens | Primates | IL-10 | IL-10 | ncbigene_synonym | IL10 | 3586 |
| Homo sapiens | Primates | TNF-a | TNF-A | ncbigene_synonym | TNF | 7124 |
| Homo sapiens | Primates | IL-2 | IL-2 | ncbigene_synonym | IL2 | 3558 |
| Homo sapiens | Primates | ↑IL-6 | IL-6 | ncbigene_synonym | IL6 | 3569 |
| Homo sapiens | Primates | B7-H3/STAT3/ | STAT3 | ncbigene_symbol | STAT3 | 6774 |
| Homo sapiens | Primates | ULBP2 | ULBP2 | ncbigene_symbol | ULBP2 | 80328 |
| Homo sapiens | Primates | IL-17 | IL-17 | ncbigene_synonym | IL17A | 3605 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| action | Action | methyl [(2-chloro-4-fluoro-5-{[(1Xi)-3-oxotetrahydro[1,3,4]thiadiazolo[3,4-a]pyridazin-1-ylidene]amino}phenyl)thio]acetate | chebi:5133 | |
| TNF-a | TNF-a | chebi:197439 | ||
| TNF-a | TNF-a | chebi:197439 |